TriSalus Life Sciences (TLSI) Stock Chart & Stock Price History → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free TLSI Stock Alerts $6.51 -0.41 (-5.92%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TriSalus Life Sciences Stock Price Performance5 Day Performance-13.08%1 Month Performance-32.61%3 Month Performance-34.90%6 Month Performance+62.75%Year-To-Date Performance-22.96% Receive TLSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. TLSI Stock Chart for Saturday, June, 8, 2024 TLSI Chart by TradingView TriSalus Life Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$6.92$6.51-5.92%$7.19$6.0047,415 shs$176.81 million06/06/2024$7.16$6.92-3.35%$7.12$6.5061,663 shs$187.95 million06/05/2024$7.36$7.16-2.72%$7.28$7.0118,636 shs$194.47 million06/04/2024$7.49$7.36-1.74%$7.48$7.1236,479 shs$199.90 million06/03/2024$7.16$7.49+4.61%$7.55$7.0524,845 shs$203.43 million05/31/2024$7.44$7.16-3.76%$7.62$7.1031,988 shs$194.47 million Get the Latest News and Ratings for TLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$7.50$7.44-0.80%$7.75$7.2263,644 shs$202.07 million05/29/2024$7.90$7.50-5.06%$7.90$7.5029,102 shs$203.70 million05/28/2024$7.56$7.90+4.50%$7.90$7.57105,541 shs$214.56 million05/27/2024$7.56$7.56$9.00$6.80353,100 shs$205.32 million05/24/2024$9.54$7.56-20.75%$9.00$6.80353,119 shs$202.31 million05/23/2024$9.68$9.54-1.45%$9.85$9.0911,534 shs$255.29 million05/22/2024$9.97$9.68-2.91%$9.95$9.615,247 shs$259.04 million05/21/2024$10.15$9.97-1.77%$10.10$9.812,983 shs$266.80 million05/20/2024$9.85$10.15+3.05%$10.17$9.6913,426 shs$271.61 million05/17/2024$9.70$9.85+1.55%$9.89$9.525,095 shs$263.59 million05/16/2024$9.39$9.70+3.30%$9.83$9.3523,620 shs$259.57 million05/15/2024$10.15$9.39-7.49%$10.07$9.3037,677 shs$251.28 million05/14/2024$10.24$10.15-0.88%$10.24$9.9014,619 shs$271.61 million05/13/2024$9.83$10.24+4.17%$10.24$9.8712,369 shs$274.02 million05/10/2024$9.80$9.83+0.31%$10.07$9.6713,892 shs$263.03 million05/09/2024$9.66$9.80+1.45%$9.96$9.678,227 shs$262.23 million05/08/2024$9.71$9.66-0.51%$9.99$9.315,826 shs$258.48 million05/07/2024$9.62$9.71+0.94%$10.10$9.6723,102 shs$259.84 million05/06/2024$9.62$9.62$10.05$9.6018,217 shs$257.43 million05/03/2024$9.34$9.62+3.00%$9.76$9.3524,438 shs$257.43 million05/02/2024$9.31$9.34+0.32%$9.55$9.3117,849 shs$249.94 million05/01/2024$9.31$9.31$9.69$9.3127,289 shs$249.14 million04/30/2024$9.37$9.31-0.59%$9.60$9.3113,237 shs$249.14 million04/29/2024$9.35$9.37+0.16%$9.56$9.11145,828 shs$250.61 million04/26/2024$9.93$9.35-5.84%$9.82$9.30205,822 shs$250.21 million04/25/2024$10.24$9.93-3.03%$10.22$9.38345,420 shs$265.73 million04/24/2024$10.20$10.24+0.39%$10.24$9.6915,607 shs$274.02 million04/23/2024$9.84$10.20+3.66%$10.20$9.8247,472 shs$272.95 million04/22/2024$9.49$9.84+3.69%$10.19$9.6810,585 shs$263.32 million04/19/2024$9.83$9.49-3.46%$9.95$9.468,546 shs$249.78 million04/18/2024$9.72$9.83+1.13%$9.99$9.5112,789 shs$258.73 million04/17/2024$9.62$9.72+1.04%$9.90$9.469,301 shs$255.83 million04/16/2024$9.50$9.62+1.26%$9.83$9.4020,339 shs$253.20 million04/15/2024$9.43$9.50+0.74%$9.88$9.3313,342 shs$250.04 millionAfter Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger…04/12/2024$9.73$9.43-3.08%$9.82$9.3143,210 shs$248.20 million04/11/2024$9.70$9.73+0.31%$10.00$9.6534,333 shs$256.09 million04/10/2024$9.80$9.70-1.02%$10.32$9.5819,660 shs$255.30 million04/09/2024$10.16$9.80-3.54%$10.14$9.6140,512 shs$257.91 million04/08/2024$9.80$10.16+3.67%$10.42$9.6028,381 shs$267.41 million04/05/2024$9.80$9.80$9.80$9.6116,640 shs$257.94 million04/04/2024$9.78$9.80+0.20%$9.80$9.5819,400 shs$257.94 million04/03/2024$9.80$9.78-0.20%$9.94$9.5019,523 shs$257.41 million04/02/2024$10.25$9.80-4.39%$10.20$9.3925,351 shs$257.94 million04/01/2024$9.75$10.25+5.13%$10.25$9.5842,205 shs$269.78 million03/29/2024$9.75$9.75$10.00$9.4615,773 shs$256.59 million03/28/2024$9.44$9.75+3.28%$10.00$9.4615,771 shs$256.62 million03/27/2024$9.32$9.44+1.29%$9.46$9.3180,083 shs$248.46 million03/26/2024$9.32$9.32$9.62$9.31140,634 shs$245.30 million03/25/2024$9.78$9.32-4.70%$10.00$9.30103,915 shs$245.30 million03/22/2024$9.47$9.78+3.27%$9.79$9.4414,496 shs$257.41 million03/21/2024$9.11$9.47+3.95%$9.70$8.8057,663 shs$249.25 million03/20/2024$9.07$9.11+0.44%$9.42$8.8151,182 shs$239.78 million03/19/2024$9.58$9.07-5.32%$9.64$9.07109,775 shs$238.72 million03/18/2024$9.73$9.58-1.54%$9.99$9.5826,743 shs$252.15 million03/15/2024$9.31$9.73+4.51%$9.85$9.3534,916 shs$256.09 million03/14/2024$9.31$9.31$9.46$9.3180,260 shs$245.04 million03/13/2024$9.36$9.31-0.53%$9.48$9.3175,080 shs$245.04 million03/12/2024$9.71$9.36-3.60%$9.90$9.3180,705 shs$246.36 million03/11/2024$10.00$9.71-2.90%$10.00$9.7142,391 shs$255.57 million03/08/2024$9.63$10.00+3.84%$10.00$9.4916,107 shs$263.20 million03/07/2024$9.99$9.63-3.60%$9.99$9.6329,409 shs$253.46 million Related Companies: Pulse Biosciences Stock Chart OrthoPediatrics Stock Chart Embecta Stock Chart Surmodics Stock Chart Paragon 28 Stock Chart SI-BONE Stock Chart Iradimed Stock Chart Bioventus Stock Chart Orthofix Medical Stock Chart Anika Therapeutics Stock Chart Receive TLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TLSI) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.